🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Prepartum Intravenous Fluid Intake on Newborn Weight Loss in the First Days of Life

Recruitingn/aAges 18 Years - anyFemaleCentre Hospitalier Universitaire, Amiens
NCT07243054 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

At birth, the infant's weight was measured daily to assess the adequacy of nutritional intake. This indicator can be influenced by various factors related to the mother, her pregnancy, as well as medical interventions during the pre-delivery phase, such as pre-partum maternal fluid intakes, and the subsequent feeding method chosen for the newborn infant. This study aimed at exploring the association between maternal vascular fluid loading during labor in the pre-partum period and neonatal weight loss in the first two days of life. The study focuses on infants fedded with infant formula. This observational, retrospective, single-center study was carried out at the Amiens University Hospital Center. The participants were mothers aged 18 and older, hospitalized in the maternity ward following full-term delivery (\> 37 weeks of gestation). Data were collected through the medical records of

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Full-term delivery (≥37+0 SA) * Singleton pregnancy * Mother over 18 years of age * Infant formula feeding exclusively in the maternity ward for the first 2 days Exclusion Criteria: * Mother under guardianship * Mother who does not understand French * Mother objecting to her personal data being reused for research purposes * Incomplete or incorrectly completed patient medical record * Mixed or exclusive breastfeeding * Mother presenting a hemodynamic disorder in the 12 hours preceding delivery, requiring a filling specifically for this reason * Child with renal pathology or uropathy * Children with cleft lip, palate or labio-palate
💊

What it tests

  • Not listed
📍

Where

1 site
CHU Amiens Picardie
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy